Search for: "In the Interest of Xr" Results 1 - 20 of 86
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Aug 2014, 5:09 pm by Lawrence B. Ebert
New Alzheimer's Drug Shows Promise It was of interest to note that commercials on CBS following the story included for Levemor (Novo Nordisk) and for Brisdelle (Noven, low dose paroxetine). [read post]
Greenpeace UK’s executive director Areeba Hamid described the protests as “the catalyst of a new united fight against the vested interests putting profits over people and the planet. [read post]
14 Jan 2022, 12:05 pm by Tom Lamb
The Health Canada Xeljanz Advisory gives some more detailed information in a section intended for healthcare professionals but, no doubt, of interest to patients using Xeljanz -- as well as Olumiant or Rinvoq, perhaps: Inform patients that Xeljanz/Xeljanz XR may increase their risk of major adverse cardiovascular events including non-fatal myocardial infarction. [read post]
14 Mar 2023, 5:16 am by Brittan Heller, Daniel Castaño
Therefore, while GAI and XR may be appropriate to help understand technical issues or optimize administrative tasks that help courts run, they should not yet be applied in adjudications where significant life, liberty, and property interests are at stake. [read post]
24 Dec 2022, 9:34 am by Katitza Rodriguez
The current excitement, however, comes from the belief that the prior iterations of virtual worlds remained niche due to technical limitations which are now being overcome by XR, rather than a lack of interest or demand from the public. [read post]
20 Apr 2018, 11:10 am by Tom Lamb
We would be interested in reviewing events of heart failure, myocardial infarction, and cerebral infarction for patients who used any of the DPP-4 diabetes drugs -- like Onlgyza, Nesina, Januvia, and Tradjenta -- as possible drug injury lawsuits against the responsible drug companies. [read post]
20 Apr 2018, 11:10 am by Tom Lamb
We would be interested in reviewing events of heart failure, myocardial infarction, and cerebral infarction for patients who used any of the DPP-4 diabetes drugs -- like Onlgyza, Nesina, Januvia, and Tradjenta -- as possible drug injury lawsuits against the responsible drug companies. [read post]
20 Sep 2018, 11:36 pm by Jeff Richardson
  (The iPhone XR will be available in stores starting October 26.) [read post]
25 Aug 2008, 3:46 am
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. [read post]
27 Jun 2011, 2:26 pm by FDABlog HPM
  What is interesting, however, is that FDA apparently does give consideration to measures of efficacy at hourly timepoints post dose. [read post]
15 May 2020, 11:59 am by Michael Cannan
However, many people that were prescribed Belviq or Belviq XR to help them lose weight in a long-term clinical trial reported feeling unwell years into the study. [read post]
19 Apr 2015, 12:09 pm
The recent journal study analyzed 21 brands of Acacia rigidula supplements; BMPEA was found in more than half, including Jet Fuel Superburn, Jet Fuel T-300, Fastin-XR. [read post]
21 Jul 2008, 3:31 am
On July 16, Impax and Wyeth announced a settlement of their litigation over Impax's generic version of Effexor XR. [read post]
29 Apr 2015, 11:07 am
We’ve often written about the conflicts of interest that can compromise patient safety when doctors and other medical providers are paid for promoting drugs, devices or services. [read post]
10 Jul 2015, 4:22 am by Lisa Larrimore Ouellette
Product hopping was recently in the news with New York state's antitrust suit against Actavis for its decision to withdraw Namenda IR, its 2x/day Alzheimer's drug (with patent protection ending July 2015), to force patients to switch to Namenda XR, a 1x/day version (with patent protection until 2029). [read post]
3 Oct 2011, 8:01 pm by FDABlog HPM
  Two recent citizen petitions of interest (here and here) concern AstraZeneca’s (“AZ’s”) quetiapine fumarate, approved as SEROQUEL (quetiapine fumarate) Tablets (NDA No. 020639) and SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets (NDA No. 022047). [read post]
27 Dec 2007, 11:00 pm
Journal had an interesting article Wednesday about Sun Pharma's generic version of Wyeth's blockbuster antidepressant Effexor XR. [read post]